News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
As Stock Rises and Baxalta (BXLT) Merger Closes, Shire (SHPG) Opens New HQ in Massachusetts with 800 Jobs 6/29/2016
Israel’s Kaiima Bio-Agritech Ltd. Expands U.S. Operations in St. Louis 6/29/2016
3 Bargain Basement Biotech Stocks That Have the Potential to Skyrocket 6/29/2016
Investors Gain Focus as Shire (SHPG) Stock Rises at Positive ADHD Drug News 6/29/2016
Infinity Pharma (INFI) Cuts Jobs by 58% as AbbVie (ABBV) Terminates Duvelisib Collaboration Deal 6/28/2016
Mayne Pharma Expands into U.S. Through the $652 Million Acquisition of 42 Generic Drugs From Allergan (AGN) and Teva (TEVA) 6/28/2016
Biotech Startup Immage Biotherapeutics (IMMG) Gets Ready for Philadelphia Expansion 6/28/2016
CRO Veristat Plans Expansion in Research Triangle Area, To Hire 150 Or More Starting Now 6/28/2016
In Light of Two Major Failed Trials, FORUM Pharma Closes Its Doors This Week 6/28/2016
How Amgen (AMGN) Fits Into Pfizer (PFE)’s Restructuring Plans 6/27/2016
Sanofi (SNY) Inks Deal to Swap Business with Boehringer Ingelheim 6/27/2016
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation 6/27/2016
NewLink Genetics (NLNK) Stock Slides and Company Lays Off 87 After Failed Trial 6/27/2016
How Brexit Is Affecting UK’s Drug Companies, Including GlaxoSmithKline (GSK), Gilead (GILD) and AstraZeneca PLC (AZN) 6/27/2016
Pfizer (PFE)’s $200 Million Facility in Massachusetts Will Create 75 Permanent Jobs 6/22/2016
5 Biotech Stocks at Bargain Basement Prices 6/22/2016
Epizyme (EPZM) to Continue Blood Cancer Trials as Tumors Were Wiped Out in Some Patients 6/21/2016
Kite Pharma (KITE) and Juno (JUNO)'s R&D Strategy to Reshape Cancer Treatment 6/21/2016
Bay Area's IMPAX Labs (IPXL) Plunks Down $586 Million for a Chunk of Teva (TEVA) and Allergan (AGN)’s Generics Portfolio 6/21/2016
Selecta's IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year 6/20/2016
As Monsanto  (MON) Bid Stalls, Bayer AG (BAYZF) Mulls Sale of $3 Billion Radiology Business 6/20/2016
4 Movers & Shakers in This Year’s Oncology Market 6/20/2016
Stock Pop Gives Hints that GlobeImmune (GBIM) Might Be Fielding Takeover Offers 6/20/2016
If Spurned By Medivation (MDVN), Sanofi (SNY) May Turn to BioMarin (BMRN) for a Little Love 6/17/2016
BioMarin (BMRN) Stock Wobbles After Hemophilia A Trial Suspended 6/17/2016
3 Battered and Bruised Life Science Stocks Ready for a Comeback 6/16/2016
Pfizer (PFE) Head of R&D Talks Strategy on How Pharma Chooses Compounds to Bet A Billion Dollars On 6/16/2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer 6/16/2016
Perrigo (PRGO) Stock Spikes on Rumors of Mystery UK Company’s $20 Billion Acquisition Bid 6/15/2016
Once Floated as Allergan (AGN) Target, Revance (RVNC)'s Stock Drops as Crow’s Feet Drug Fails Trial 6/14/2016
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial 6/14/2016
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application 6/14/2016
Looking at the Odds, Pfizer (PFE), Incyte (INCY) or Merck & Co. (MRK) Will Gobble Up Tiny Agenus (AGEN) 6/14/2016
Bay Area's diaDexus Files Chapter 7 Bankruptcy, Plans to Liquidate Assets, CFO to Step Down Immediately 6/14/2016
5 Biotech Stocks for Investors Who Want Long-Term Returns 6/13/2016
Sam Waksal, Part of the Martha Stewart Insider Trading Scandal, Exits Kadmon as Company Files for $115 Million IPO 6/13/2016
Days After Judge Overturns Merck & Co. (MRK)-Gilead (GILD) Lawsuit, Merck Acquires Bay Area's Afferent Pharma for $1.2 Billion 6/10/2016
Amid Plunging Stocks and Failed Trials, Biogen (BIIB)’s CIO Quietly Leaves Company 6/10/2016
3 Life Science Stocks Millennials Should Watch Over the Long Haul 6/10/2016
Amgen (AMGN) Shows Off Mid-Stage Migraine Data, Needs to Compete With Eli Lilly (LLY), Teva (TEVA) and Alder Biopharma 6/9/2016
BIO2016: The State of the Biotech Innovation and Drivers of Forecasting Success 6/9/2016
Mologen (MOLGF.PK) Restructures, Pushes Immunology Program, Shelves Renal Cancer Vaccine 6/9/2016
Biogen (BIIB) Loses $8 Billion in Market Value in One Day After Failed Trial 6/8/2016
Rho's Mission to Headhunt for New Employees at DIA 2016 6/8/2016
BIO2016: Where the Bioscience Jobs Are and the Current Trends 6/8/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy 6/8/2016
Former Pfizer (PFE) Employee and Childhood Friend Busted on Insider Trading Scheme 6/7/2016
Allergan (AGN) CEO Dishes on Strategy and Some Of His Battles Over Deals And Mergers 6/7/2016
Sarepta (SRPT) Surges Yet Again, as the FDA Requests More Data About Duchenne’s Drug 6/7/2016
Former Medivation (MDVN) CMO Takes Helm at Roivant Sciences-Takeda (TKPYY)'s Newly Launched Company Myovant Sciences 6/6/2016
ASCO2016: AbbVie (ABBV) Pushes R&D, While Stemcentrx's Lung Cancer Drug Shows Early Promise 6/6/2016
ASCO2016: After NantHealth (NH) Explodes onto the Market, Patrick Soon-Shiong Prepares for Two More 6/6/2016
Rumors Floating Again that Roche (RHHBY) or GlaxoSmithKline (GSK) Might Acquire Bay Area’s Pacific Biosciences (PACB) 6/3/2016
Pfizer (PFE) Boss Discusses M&A Strategy and Says No to Tax Inversions 6/3/2016
Why Sanofi (SNY) is So Infatuated With the Bay Area’s Medivation (MDVN) 6/3/2016
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex (CLDX) Stock 6/3/2016
Patrick Soon-Shiong's NantHealth (NH) Explodes onto Market in IPO Debut 6/3/2016
Novartis AG (NVS) Employees in Shanghai Get a New $1 Billion Home 6/2/2016
All Eyes Turn to Sarepta (SRPT) as BioMarin (BMRN) Shutters Its Kyndrisa Duchenne Program 6/2/2016
Roche (RHHBY) and Novartis AG (NVS) Gear Up to Battle Over Biosimilars 6/2/2016
Activist Investor Carl Icahn's Big Buy of Allergan (AGN) Shares Raises Questions of Influence 6/1/2016
2 Potentially Hot Biotech Stocks Currently Under $5 Per Share 6/1/2016
Why Intercept Pharma (ICPT) Just Became an Even More Attractive Takeover Target 6/1/2016
Bad News for AstraZeneca PLC (AZN) is Good News for Relypsa (RLYP) 5/31/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance 5/31/2016
Gilead (GILD), Biogen (BIIB), Jazz Pharma (JAZZ) Subpoenaed as Feds Investigate Drugmaker-Charity Connections 5/27/2016
3 Biotech Stocks Flying High Under-the-Radar 5/27/2016
FORUM Pharma CEO Quits Amid Layoffs and a Possible Company Shutdown 5/27/2016
Titan Pharma (TTNP) Receives FDA Approval for the First Ever Implantable Device for Opioid Dependency 5/27/2016
Making Sense of Alnylam (ALNY)’s Recent Stock Surge 5/27/2016
Nine Bay Area Biotechs Vie to be the “Next Genentech (RHHBY)” 5/26/2016
Sarepta (SRPT) Rockets After the FDA Delays Ruling on DMD Drug 5/26/2016
Serial BioPharma Entrepreneurial Team Launches Arrivo BioVentures with $49 Million 5/25/2016
Amid Restructuring and Lawsuits, Novartis AG (NVS) Indicates It Might Sell $14 Billion Roche (RHHBY) Stock Without a Premium 5/25/2016
Eli Lilly (LLY) Projects 20 New Product Launches in 10 Years with 20 Possible Expansions 5/25/2016
Bicycle Therapeutics Sets Up Shop in Massachusetts, Taps a New President and CBO 5/24/2016
Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company XenoPort (XNPT) 5/24/2016
Amid Shareholder Pressure, Bayer AG (BAYZF) Makes Formal $62 Billion Bid for Monsanto  (MON) 5/24/2016
Amgen (AMGN) Researchers Discover Gene that Cuts Heart Attack Risk 5/23/2016
Sarepta (SRPT) Who? This DMD Drugmaker Might be a Better Buy for Investors 5/23/2016
13 Massachusetts Cancer Biotechs Looking to Shake Things Up at ASCO in June 5/20/2016
Bill & Melinda Gates Foundation Gets $86.7 Million Windfall After Taking a $5 Million Stake in Anacor (ANAC) Three Years Ago 5/20/2016
Genentech (RHHBY) Nabs FDA Approval of First New Bladder Cancer Drug in 30 Years 5/20/2016
Agios (AGIO), Celgene (CELG) Hammer Out $1 Billion+ Metabolic Immuno-Oncology Deal 5/19/2016
MacroGenics (MGNX) Wrangles Cancer Deal Worth $755 Million Out of Johnson & Johnson (JNJ) 5/19/2016
Eli Lilly (LLY) and Regeneron (REGN) Tips: How to Find Your First Biopharma Job Right Out of College 5/19/2016
AstraZeneca PLC (AZN)'s Asthma Drug Hits Phase III Goal, Predicted to Reach Market in 2017 5/18/2016
In Another Small Deal, Pfizer (PFE) Slams Down $5.2 Billion for Bay Area Drugmaker Anacor (ANAC) 5/17/2016
Bay Area's Relypsa (RLYP) Falls on Unimpressive Veltassa Script Data 5/17/2016
Delving Into Pfizer (PFE)’s Anacor (ANAC) Acquisition Strategy and Its Impact on Regeneron (REGN) 5/17/2016
After Heart Drug Flunks Phase II Study, Trevena (TRVN) Makes Strategic Pivot to Focus on Pain Drugs 5/16/2016
Pfizer (PFE) Joins 24 Other Companies in Blocking Use of 7 Drugs for Lethal Injections 5/16/2016
Only Days After a Follow-On Offering, San Diego's Sophiris Bio (SPHS) Hires Oppenheimer to Explore Strategic Options 5/13/2016
Pfizer (PFE) Shows Off TRUMENBA Data from Two Large-Scale Phase III Trials 5/13/2016
Regeneron (REGN) CEO Says Critique of the Company's New Cholesterol Lowering Therapy Was Non-Scientific 5/13/2016
Why Pfizer (PFE)'s Pipeline and Products May Have an Edge Over Merck & Co. (MRK) 5/13/2016
GlobeImmune (GBIM) Considers Sales or Closure After Bleak Q1 Financials 5/13/2016
Bayer (BAY) Rumored to be Exploring Bid for $40 Billion Seed Company Monsanto  (MON) 5/12/2016
Massachusetts’ PixarBio Hiring at New Jersey Site to Respond to Opioid Crisis 5/12/2016
Dermatology Company Galderma Laboratories Expands HQ and Brings on 400+ Jobs in Support of Nine New Product Launches 5/12/2016
Bay Area's ChemoCentryx (CCXI) Inks $85 Million Deal With Vifor Pharma for Lead Product Candidate 5/12/2016
Seattle-Based Omeros (OMER) Beefs Up Salesforce as Cataract Surgery Drug Sales Take Off in Q1 5/11/2016
Hours After Debuting Biotech Startup Vor BioPharma, PureTech Launches Alivio Therapeutics 5/11/2016
EPIRUS Biopharma to Slash 40% of Workforce, Suspend Lead Clinical Program and Replaces CEO 5/11/2016
Pulitzer Prize Author of “Emperor of All Maladies” Launches Biotech Startup Vor BioPharma in Boston 5/11/2016
Medivation (MDVN) Takeover Saga Takes Another Turn, Rumored to Open Books to Amgen (AMGN) and Pfizer (PFE) 5/11/2016
Gilead (GILD) CEO Targets Cancer Acquisitions with $21 Billion Cash Pile 5/10/2016
Facebook's Oculus Rift Developer Resigns to Work on Wearable MRI Startup 5/9/2016
Incyte (INCY) Buys Ariad (ARIA)'s EU Operations and Iclusig Rights for $140 Million Upfront 5/9/2016
Sanofi (SNY) Heats Up Medivation (MDVN) Bid With Letter Threatening a Hostile Takoever 5/6/2016
Pfizer (PFE) Turns to WAVE Life Sciences (WVE) for Drug Discovery in Deal Worth $911 Million 5/6/2016
Startup Hera BioLabs Builds $1.8 Million Headquarters and Creates 23 New Jobs 5/6/2016
Amid Restructuring and Rumors of a LabCorp (LH) Merger, CRO INC Research (INCR) Lays Off 175 5/5/2016
2 Biotechs Investors Should Pick Up Before Key PDUFA Dates 5/5/2016
Biogen (BIIB)'s Hemophilia Spinoff Suggests M&A Activity Could Be On the Horizon 5/5/2016
Bay Area’s Medivation (MDVN) Shores Up Defenses as Pfizer (PFE) Rumored to Join Sanofi (SNY) in Acquisition Bid 5/4/2016
3 Stocks with Moonshot Potential that are Safer Buys than bluebird bio (BLUE) 5/4/2016
Amid Hemophilia Spinoff, Biogen (BIIB)’s Head of Strategy Returns to Bain Capital 5/4/2016
Biogen (BIIB) Spinning Off Hemophilia Business to Focus On Neurological Disorders 5/4/2016
Pfizer (PFE) Rumored to be Selling Its Hospira Pumps Division, With Smiths Group, Fresenius SE and Pamplona Capital Bidding 5/3/2016
AstraZeneca PLC (AZN) to Cut Jobs in $1.5 Billion Cost-Cutting Move, Will Double Down on Cancer 5/2/2016
EMD Serono Expansion to Create 150 New Jobs in Massachusetts 5/2/2016
Abbott (ABT) Tries to Back Out of $5.8B Alere (ALR) Deal, But Alere Says It’s Still On 5/2/2016
Startup Homology Medicines Launches With $43 Million Series A, To Be Led By Three Former Shire (SHPG) Execs 5/2/2016
Medivation (MDVN) Says No! to Sanofi (SNY)'s $9.3 Billion Hostile Bid 4/29/2016
AbbVie (ABBV) Pays $5.8 Billion+ for Bay Area's Stemcentrx, Which Has Ties to Paypal and SpaceX Investors 4/29/2016
AstraZeneca PLC (AZN) Stays Mum on M&A, Says “No Comment” to Medivation (MDVN) Bid 4/29/2016
Sanofi (SNY) Makes Hostile $9.3 Billion Bid for Bay Area’s Medivation (MDVN) 4/29/2016
Abbott (ABT)'s $25 Billion Bid for St. Jude Medical (STJ) Raises Questions About Pending Alere (ALR) Deal 4/28/2016
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response 4/28/2016
The M&A Rumor Mill Points to Gilead (GILD) Acquiring Intercept Pharma (ICPT) 4/28/2016
Rounding Up the Experts’ Thoughts on What's Next for Sarepta (SRPT)'s DMD Drug 4/27/2016
Rumors Surface Again About AstraZeneca PLC (AZN), Sanofi (SNY) or AbbVie (ABBV) Acquiring Medivation (MDVN) 4/27/2016
Amid Positive First Quarter Financials, GlaxoSmithKline (GSK) Boss Expects a Late 2016 Replacement 4/27/2016
FDA Panel’s 7-6 Vote Against Sarepta (SRPT)’s DMD Drug Underlines Battle Between Science and Patient Advocates 4/26/2016
Crystal Ball Gazing: Amgen (AMGN)’s Q1 Financials, What to Look For 4/26/2016
Novartis AG (NVS) Mulls Over Selling $14 Billion Roche (RHHBY) Stake to Potentially Free Up Cash for New Deals 4/26/2016
2 Small Biotech Companies Poised to Take Flight 4/25/2016
Sarepta (SRPT)’s Stock a Rollercoast Ride Prior to Today’s FDA Hearing 4/25/2016
Bay Area’s Relypsa (RLYP) Stock Pops (Again) on More Buyout Rumors 4/25/2016
Allergan (AGN) Makes Another Deal, Bags Boston's Topokine for $85 Million+ 4/25/2016
Biogen (BIIB), Regeneron (REGN) and Valeant (VRX) Rank High as Potential Takeover Targets for Allergan (AGN) 4/22/2016
Concordia (CXR.TO) Stock Rockets on Rumors of a Blackstone Buyout 4/22/2016
Sarepta (SRPT) Craters as the FDA Releases Documents Ahead of Monday’s DMD Drug Hearing 4/22/2016
GlaxoSmithKline (GSK) May Need To Sweeten the Pot to Lure in A New CEO 4/21/2016
3 Biotech Stocks to Withstand the Presidential Race 4/21/2016
As Part of Worldwide Expansion, Novo Nordisk A/S (NVO) Spends 100 Million Euros to Build in France 4/21/2016
Backed by Pfizer (PFE) and Roche (RHHBY), Bay Area's Second Genome Nabs $42.6 Million 4/21/2016
French DMD-Focused Biotech, Anagenesis Biotherapies, Sets Up Shop in Boston 4/20/2016
4 Life Science Startups to Watch 4/19/2016
Allergan (AGN)'s Potential Shopping List Expands 4/19/2016
Startup with Bay Area Ties, DalCor, Secures $150 Million Financing and to Launch Phase III Trial 4/19/2016
A Week After Medivation (MDVN) Rumored to Snub Sanofi (SNY) Bid, AstraZeneca PLC (AZN) in Talks to Make Its Own $10 Billion Offer 4/19/2016
Cholesterol Drugmaker Gemphire Files for $60 Million IPO 4/19/2016
Bay State's Enumeral Biomedical (ENUM) Signs $106.3 Million+ Immuno-Cancer Deal With Pieris 4/18/2016
After FDA Type A Meeting, Telesta (TSX:TST) Eyes Major Restructuring and a Partner to Continue Phase III Trial 4/18/2016
Promising Hep B Drug Makes SoCal's Arrowhead Pharma (ARWR) a Pretty Target for Gilead (GILD) and Other Big Companies 4/15/2016
Pfizer (PFE) Mulling Over $200 Million Facility that Could Bring 150 New Jobs to Massachusetts 4/15/2016
If Pfizer (PFE) Wants to Buy, Here’s a Shopping List 4/15/2016
Simmering Power Struggle Between Depomed (DEPO) and Hedge Fund Starboard Value Comes to a Boil 4/15/2016
Redx Pharma Consolidates Three Business Units and Sets Up Shop at Ex-AstraZeneca PLC (AZN) Site 4/15/2016
Bristol-Myers Squibb (BMY) Will Add Third Building to Bay Area Campus, Could Up Headcount by 150 Employees 4/15/2016
New Jersey's Catalent (CTLT) Jumps on Rumors of Lonza Group (LZAGY.PK)'s Takeover Bid 4/14/2016
NephroGenex (NRX), Under Threat of Being Delisted from the NASDAQ, Fires CEO and CSO 4/14/2016
Bay Area’s Medivation (MDVN) Stock Pops 11% After Rumors It Rejected A Sanofi (SNY) Acquisition Bid 4/14/2016
3 Life Sciences Companies Heading Into Orbit or On the Launching Pad 4/13/2016
While Exploring Sale of Its Hemophilia Unit, Some Speculate Biogen (BIIB) Might be Prepping to Buy or be Acquired 4/13/2016
Massachusetts' Mucus Penetrating Eye Disease Firm Kala Pharma Raises $68 Million 4/13/2016
In a Volatile Biotech Market, Here are 3 Stocks To Consider 4/12/2016
Google (GOOG)'s Verily Stumbles Amid CEO's Questionable Business Approach and Ethics Allegations 4/12/2016
Sources Reveal Biogen (BIIB) is Exploring Sale of Hemophilia Assets 4/12/2016
Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC (AZN) to Identify New Cholesterol Drugs 4/11/2016
Happy 40th Birthday, Genentech (RHHBY) 4/11/2016
Bay Area’s Relypsa (RLYP) Stock Pops At Sale Rumors While Waiting For Potential AstraZeneca PLC (AZN) Competition 4/11/2016
A Day After The Pfizer (PFE)-Allergan (AGN) Deal Dies, Allergan Inks Potential $3.3 Billion Alzheimer’s Deal with Heptares 4/11/2016
Investors Assure Pfizer (PFE)’s Ian Read: We Have Your Back 4/8/2016
The 5 Best Life Science Companies with Great Perks and Work Culture 4/8/2016
Three Pfizer (PFE) Execs to Receive $1 Million Retention Bonuses Each After Allergan (AGN) Deal Dies 4/8/2016
Shire (SHPG) Not Spooked by Pfallergan Breakup, Remains Committed to Baxalta (BXLT) 4/7/2016
Genomics Giant Illumina (ILMN) Inks Huge Lease for San Diego i3 Campus 4/7/2016
Pfizer (PFE) Formally Calls Off $160 Billion Allergan (AGN) Deal 4/7/2016
Nixed Pfallergan Deal Has Investors Wondering if Allergan (AGN) Might Target Biogen (BIIB) 4/7/2016
Companies Allergan (AGN) Could Buy if Deal with Pfizer (PFE) Falls Through 4/6/2016
U.S. Treasury Drops Bomb on Tax Inversion Deals, Threatens Pfizer (PFE)-Allergan (AGN) Merger 4/6/2016
Pfizer (PFE) Inside Source Says Company Considering Abandoning Allergan (AGN) Deal 4/6/2016
Data Behind Eli Lilly (LLY)'s Decision to Halt Potential Cholesterol Blockbuster Released Last Weekend 4/5/2016
Lexicon Pharma (LXRX) Shifts Texas Expansion Amid $1.4 Billion+ Sanofi (SNY) Deal and New Drug Application 4/5/2016
Why SoCal's Acadia (ACAD) May Be a Perfect Takeover Target for Biogen (BIIB) 4/5/2016
Spotlight on Immigrant Life Science Company Leaders in Massachusetts 4/5/2016
Pfizer (PFE) Becomes Victim of Pre-April Fool's Day Press Release Scam 4/4/2016
Two Drugmakers Johnson & Johnson (JNJ) May Consider Scooping Up 4/4/2016
Takeda (TKPYY) and Teva (TEVA) Establish New Biz Venture “Teva Takeda Yakuhin Ltd.” for Japanese Generics 4/1/2016
Top 5 Biotech Winners and Losers of Q1 2016 4/1/2016
San Francisco's Medivation (MDVN) Hires J.P. Morgan to Head Off Acquisition Attempts 4/1/2016
For a Possible Gilead (GILD)-Celgene (CELG) Deal, Let Us Count the Ways 4/1/2016
PureTech Launches Another Startup Commense in Boston 4/1/2016
Mallinckrodt (MNK) Rumored to be Eyeing Sale of Nuclear Imaging Unit, Biz Could Fetch $800 Million to $1 Billion 3/31/2016
3 Biotechs that Don't Require Day-to-Day Monitoring 3/30/2016
As Flailing Valeant (VRX) Pushes Back Earnings Deadlines, Bausch & Lomb Sale Potentially on the Table 3/30/2016
Sanofi (SNY) Poaches Top AstraZeneca PLC (AZN) Scientist 3/30/2016



//-->